AGL 39.12 Decreased By ▼ -0.88 (-2.2%)
AIRLINK 128.63 Decreased By ▼ -0.43 (-0.33%)
BOP 6.80 Increased By ▲ 0.05 (0.74%)
CNERGY 4.65 Increased By ▲ 0.16 (3.56%)
DCL 8.50 Decreased By ▼ -0.05 (-0.58%)
DFML 41.05 Increased By ▲ 0.23 (0.56%)
DGKC 82.30 Increased By ▲ 1.34 (1.66%)
FCCL 33.25 Increased By ▲ 0.48 (1.46%)
FFBL 73.40 Decreased By ▼ -1.03 (-1.38%)
FFL 11.76 Increased By ▲ 0.02 (0.17%)
HUBC 109.45 Decreased By ▼ -0.13 (-0.12%)
HUMNL 14.28 Increased By ▲ 0.53 (3.85%)
KEL 5.22 Decreased By ▼ -0.09 (-1.69%)
KOSM 7.63 Decreased By ▼ -0.09 (-1.17%)
MLCF 39.07 Increased By ▲ 0.47 (1.22%)
NBP 63.75 Increased By ▲ 0.24 (0.38%)
OGDC 192.75 Decreased By ▼ -1.94 (-1%)
PAEL 25.60 Decreased By ▼ -0.11 (-0.43%)
PIBTL 7.32 Decreased By ▼ -0.07 (-0.95%)
PPL 153.26 Decreased By ▼ -2.19 (-1.41%)
PRL 25.39 Decreased By ▼ -0.40 (-1.55%)
PTC 17.26 Decreased By ▼ -0.24 (-1.37%)
SEARL 77.80 Decreased By ▼ -0.85 (-1.08%)
TELE 7.65 Decreased By ▼ -0.21 (-2.67%)
TOMCL 33.35 Decreased By ▼ -0.38 (-1.13%)
TPLP 8.35 Decreased By ▼ -0.05 (-0.6%)
TREET 16.41 Increased By ▲ 0.14 (0.86%)
TRG 56.49 Decreased By ▼ -1.73 (-2.97%)
UNITY 27.51 Increased By ▲ 0.02 (0.07%)
WTL 1.37 Decreased By ▼ -0.02 (-1.44%)
BR100 10,499 Increased By 53.7 (0.51%)
BR30 31,081 Decreased By -108.2 (-0.35%)
KSE100 98,049 Increased By 250.6 (0.26%)
KSE30 30,580 Increased By 99.1 (0.33%)

China stocks rallied on Thursday to post their biggest monthly advance since December, after positive trial results for a drug to treat COVID-19 and downbeat data reinforced hopes of further stimulus to bolster the world's second-largest economy.

The blue-chip CSI300 index ended up 1.2% at 3,912.58, while the Shanghai Composite Index closed 1.3% higher at 2,860.08. For the week, CSI300 gained 3.1%, while SSEC added 1.8%.

For the month, CSI300 climbed 6.1%, while SSEC was up 4%, both posted their best monthly rise since last December, as investors cheered the reopening of some parts of the country and a raft of stimulus measures.

On the macro front, data showed China's official Purchasing Managers' Index (PMI) eased to 50.8 in April from 52 in March. While twin surveys showed China's factories suffered a collapse in export orders in April, suggesting a full-blown recovery appeared some way off.

The latest data is not that surprising, as China has the best economic recovery in the world as it has basically brought the coronavirus outbreak under control, said Yan Jinkui, an analyst with Caida Securities.

Amid the global monetary easing, why should China stocks fall at this moment, while markets overseas rally where virus control is not that good, he added.

A populous region in northern China that includes Beijing will ease restrictions imposed to halt the spread of the new coronavirus, as the country gradually transitions to a new state of normal amid dwindling cases of COVID-19.

Top US infectious disease official Anthony Fauci said Gilead's antiviral remdesivir will become the standard of care for COVID-19 after early results showed it helped patients recover more quickly from the illness caused by the coronavirus.

China's transport ministry said on Thursday it has a pool of transportation projects with a total investment value of 800 billion yuan ($113.02 billion) that can start as soon as funding is guaranteed.

Copyright Reuters, 2020

Comments

Comments are closed.